American Flag

Health Care

Public Policy and Health Care Sector Reform

Public Policy and Health Care Sector Reform

In the health and pharmaceutical sectors, NERA economists have broad experience helping corporations and governments achieve "value for money" through the design of institutional and regulatory frameworks. From devising a new framework for health financing in the UK to advising the Lebanese government on a vision for health policy to assisting the Montana Attorney General on how to regulate hospital pricing, our consultants are experienced in applying their knowledge of "what works" in different policy environments. In the same way, we also help corporations such as hospitals, insurers, pharmaceutical companies, and industry associations understand the implications of changing policy environments and how best to respond to them.

Name Title Location Phone Email
Dr. Lawrence Wu President San Francisco +1 415 291 1007 lawrence.wu@nera.com
Dr. Denise Neumann Martin Managing Director New York City +1 212 345 5296 denise.martin@nera.com
Title Type Author
Drug Rebates: A Peek Behind the Curtain at Drug Prices Published Article Dr. Christopher Stomberg
Taking Stock of the Efficiencies Defense: Lessons from Recent Health Care Merger Revi... Published Article Dr. Subramaniam Ramanarayanan
Paper Trail: Review of a Recent Working Paper on the Effect of Copay Coupons on Drug ... Published Article Bryan Ray and Dr. Subbu Ramanarayanan
Reimbursing Generics in the UK: Is There a Better Way? Published Article By NERA Special Advisor Ian Senior
Risk-Adjustment and Its Implications for Efficiency and Equity in Health Care Systems Report By Dr. Thomas McCarthy with Keith Davies, John Gaisford and Ullrich Hoffmeyer